Objetivo nº3: Modelar, diseñar y caracterizar elementos ópticos

1. Jellin JM, Batz F, Hitchens K. Natural Medicines Comprehensive Database, 3rd ed.

Stockton, CA: Therapeutic Research Faculty, 2002:1530.

2. Sheng WD, Jiddawi MS, Hong XQ, Abdulla SM. Treatment of chloroquine-resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole. East Afr Med J 1997; 74:283–284.

3. Rabbani GH, Butler T, Knight J, Sanyal SC, Alam K. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 1987; 155:979–984.

4. Swabb EA, Tai YH, Jordan L. Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. Am J Physiol 1981; 241:G248–G252.

5. Khosla PK, Neeraj VI, Gupta SK, Satpathy G. Berberine, a potential drug for tra-choma. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 1992; 69:147–165.

6. Mohan M, Pant CR, Angra SK, Mahajan VM. Berberine in trachoma. (A clinical trial). Indian J Ophthalmol 1982; 30:69–75.

7. Zeng X, Zeng X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed Chromatogr 1999; 13:442–444.

8. Mahady GB, Pendland SL, Stoia A, Chadwick LR. In vitro susceptibility of Helico-bacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis. Phytother Res 2003; 17:217–221.

9. Gentry EJ, Jampani HB, Keshavarz-Shokri A et al. Antitubercular natural products:

berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, beta-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2. J Nat Prod 1998; 61:1187–1193.

10. Wu AH, Forte E, Casella G et al. CEDIA for screening drugs of abuse in urine and the effect of adulterants. J Forensic Sci 1995; 40:614–618.

11. Mikkelsen SL, Ash KO. Adulterants causing false negatives in illicit drug testing.

Clin Chem 1988; 34:2333–2336.

12. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 2000; 97:1433–1437.

13. Stermitz FR, Tawara-Matsuda J, Lorenz P et al. 5-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus. J Nat Prod 2000; 63:1146–1149.

14. Anis KV, Rajeshkumar NV, Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol 2001; 53:763–768.

15. Chung JG, Chen GW, Hung CF et al. Effects of berberine on arylamine N-acetyl-transferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells. Am J Chin Med 2000; 28:227–238.

16. Fukuda K, Hibiya Y, Mutoh M et al. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 1999;

66:227–233.

17. Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate 1993;

63:201–208.

18. McGuffin M, Hobbs C, Upton R, Goldberg A. American Herbal Products Association’s Botanical Safety Handbook. Boca Raton, FL: CRC Press, 1997:231.

19. Farnsworth NR, Bingel AS, Cordell G, Crane FA, Fong HH. Potential value of plants as sources of new antifertility agents I. J Pharm Sci 1975; 64:535–598.

20. Brinker F. The Toxicology of Botanical Medicines. Sandy, OR: Eclectic Medical Publications, 2000:296.

21. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-care Professionals. London, UK: Pharmaceutical Press, 1996:296.

22. Weber HA, Zart MK, Hodges AE et al. Method validation for determination of alkaloid content in goldenseal root powder. J AOAC Int 2003; 86:476–483.

23. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics, 2nd ed. New York, NY: John Wiley & Sons, 1996:649.

24. Abel G. [Chromosome-damaging effect of beta-asaron on human lymphocytes].

Planta Med 1987; 53:251–253.

25. Hwang BY, Roberts SK, Chadwick LR, Wu CD, Kinghorn AD. Antimicrobial con-stituents from Goldenseal (the Rhizomes of Hydrastis canadensis) against selected oral pathogens. Planta Med 2003; 69:623–627.

26. Scazzocchio F, Cometa MF, Tomassini L, Palmery M. Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. Planta Med 2001;

67:561–564.

27. Ghosh AK, Bhattacharyya FK, Ghosh DK. Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp Parasitol 1985; 60:404–413.

28. Ghosh AK, Rakshit MM, Ghosh DK. Effect of berberine chloride on Leishmania donovani. Indian J Med Res 1983; 78:407–416.

29. Mahajan VM, Sharma A, Rattan A. Antimycotic activity of berberine sulphate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982; 20:79–81.

30. Goel M, Singh UP, Jha RN, Pandey VB, Pandey MB. Individual and combined effect of (/)-alpha-hydrastine and (/)-beta-hydrastine on spore germination of some fungi. Folia Microbiol (Praha) 2003; 48:363–368.

31. Foster S, Tyler VE. Tyler’s Honest Herbal. Binghamton, NY: Haworth Herbal Press, 1999.

32. Huang CG, Chu ZL, Wei SJ, Jiang H, Jiao BH. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells. Thromb Res 2002;

106:223–227.

33. Rehman J, Dillow JM, Carter SM et al. Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensis. Immunol Lett 1999; 68:391–395.

34. Ivanovska N, Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol 1996;

18:553–561.

35. Ivanovska N, Philipov S, Hristova M. Influence of berberine on T-cell mediated immunity. Immunopharmacol Immunotoxicol 1999; 21:771–786.

36. Kupeli E, Kosar M, Yesilada E, Husnu K, Baser C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci 2002; 72:645–657.

37. Yesilada E, Kupeli E. Berberis crataegina DC. root exhibits potent anti-inflammatory, analgesic and febrifuge effects in mice and rats. J Ethnopharmacol 2002; 79:237–248.

38. Zhang MF, Shen YQ. [Antidiarrheal and anti-inflammatory effects of berberine].

Zhongguo Yao Li Xue Bao 1989; 10:174–176.

39. Li H, Miyahara T, Tezuka Y et al. The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine. Biol Pharm Bull 1999;

22:391–396.

40. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000; 7:273–282.

41. Brinker F. Herb Contraindications and Drug Interactions, 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.

GREEN TEA